Lisa Ricciardi, President and CEO of Cognition Therapeutics, was recently a guest on Benzinga's All-Access. Cognition ...

Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

Dementia affects more than 6 million Americans and accounts for more than 100,000 deaths each year, with a startling NYU ...

What’s exciting is that medications that block CXCR3 are already being tested for other health problems, like arthritis. If ...

Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are ...

Medically reviewed by Forest Miller, OTR/L Agitation is commonly seen in people with dementia. It's typically caused by a combination of external factors and neurobiological (relating to the structure ...

New research provides further evidence that getting uncontrolled high blood pressure under control could be one way to reduce ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...

Memory loss is a potential sign of dementia that occurs in progressive stages. Learn about treating and preventing dementia ...

Pseudodementia had sometimes been linked to any factitious mental illness, however, in the 1960s the term came to be known ...

Imagine discovering that up to one in three dementia cases could be prevented with something as simple as treating hearing ...

Lowering high blood pressure reduces dementia risk by 15%, as shown in a clinical trial involving 34,000 patients in China.